BioSpace News Archive

Deals

Alexion Set to Acquire Portola Pharmaceuticals in $1.41 Billion Deal

Alexion said the acquisition of Portola will bolster its commercial portfolio and create long-term value for its shareholders.

May 5, 2020
·
3 min read
·
Alex Keown
Lone Star Bio

Luminex Returns to Profitability, Thanks – Partially – to COVID-19

Luminex, a developer of molecular diagnostics and clinical tools for the life sciences industry, returned to profit this quarter – well ahead of schedule – after a major client, LabCorp, departed in 2019.

May 5, 2020
·
4 min read
·
Gail Dutton
Drug Development

Sanofi and Regeneron’s Libtayo Shows Benefit in Basal Cell Carcinoma

Sanofi and Regeneron are focusing on basal cell carcinoma treatment and their drug Libtayo is showing good results. The companies expect to make regulatory submissions this year.

May 5, 2020
·
3 min read
·
Mark Terry
Genetown

Praxis Shares Details of Pipeline, Garners $100M in Financing

Praxis is currently focused on leveraging its research on the genetics of epilepsy. Using its insights, the company is currently working on a pipeline of treatments that address the genes that control the imbalance of excitation and inhibition of neuronal circuitry.

May 5, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Akebia Soars on Positive Phase III Data for Kidney Disease Drug Vadadustat

Akebia Therapeutics’ investigational drug vadadustat hit the mark in the first of two Phase III trials in chronic kidney disease (CKD) patients who are on dialysis, and investors are pleased.

May 5, 2020
·
2 min read
·
Alex Keown
Business

Dr. Fauci Dismisses COVID-19 Conspiracy Theories, Talks Vaccines in Interview

In an interview with National Geographic, Fauci once again sided with the evidence that indicates the virus is a species jumper and originated in the animal kingdom.

May 5, 2020
·
3 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: May 5

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 5, 2020.

May 5, 2020
·
6 min read
·
BioSpace Editorial Staff
Business

World Leaders Pledge Billions of Dollars to Fund and Distribute COVID-19 Vaccine

Leaders from all over the world met for a virtual summit on Monday, May 4 to pledge billions of dollars to fund development of a vaccine against COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Noticeably absent was the United States.

May 5, 2020
·
3 min read
·
Mark Terry
Business

MilliporeSigma CEO Udit Batra Shares His Secrets for Career Success

In 1996, Udit Batra received his Ph.D. in chemical engineering from Princeton University. 24 years later, he heads a MilliporeSigma, $7.5 billion global life sciences company with a catalog of some 300,000 items used by life sciences researchers and developers throughout the world.

May 5, 2020
·
4 min read
·
Gail Dutton
Business

MacroGenics Provides Update on Corporate Progress and First Quarter 2020 Financial ResultsConference call scheduled for today at 4:30 p.m. ET.

MacroGenics, Inc. provided an update on its corporate progress and reported financial results for the quarter ended March 31, 2020.

May 5, 2020
·
10 min read